Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,586.84
(
0.46%
)
US TECH 100
23,491.60
(
0.57%
)
Dow Jones
46,400.19
(
0.60%
)
Brent Oil
98.56
(
2.13%
)
Bitcoin
70,913.00
(
0.56%
)
News Focus
News Focus
Post# of 30495
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122810
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 19783

Wednesday, 10/16/2019 9:21:02 AM

Wednesday, October 16, 2019 9:21:02 AM

Post# of 30495
ABT 3Q19 sales by business segment: 
  
 Medical devices* 38% (+11% YoY in const currency) 
 Diagnostics      24% ( +7% YoY in const currency) 
 Nutrition        23% ( +3% YoY in const currency) 
 Drugs†           15% ( +8% YoY in const currency)
65% of overall sales were ex-US.

*Including diabetes care.
†Branded generics in emerging markets.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today